Editors’ Picks, March 2024: Synergy’s Impact on Resistance, New Early Detection Tools, and More
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Three patients share their experiences about having Lynch syndrome.
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.
Lobular breast cancer accounts for 15% of all breast cancer cases, but it is understudied.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
This quarter’s new tools and strategies for cancer research included molecular jackhammers and biobots that crawl.
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...